Benson Viscometers, based in Haverfordwest, Wales is the market leader in the UK and Ireland for clinical viscometers, instruments which can be used to measure the viscosity, or thickness, of blood. They work by drawing a small sample of plasma through a narrow capillary using a constant pressure and measuring the time taken for the sample to move a known distance.
A clinical blood viscosity diagnostic device, manufactured by a small company in Wales, is becoming an important tool for understanding how Covid-19 affects the body. Verdict Medial Devices investigates.
At Addenbrookes Hospital in the UK, the company’s equipment is now being used to explore how best to understand and treat Covid-19. Clinicians have been carrying out viscometry tests on all Covid-19 patients to establish a link between blood viscosity and the viral disease, and explore how it may relate to disease severity and recovery. Health Services Laboratories in London is also on the case, using blood viscosity tests to monitor inflammatory status in certain groups of Covid-19 patients, exploring the possibility that high inflammatory markers might indicate the need for alternative strategies for stroke prevention in these patients.
The COVID-19 outbreak is currently going the world over, the plasma viscosity report covers the impact of the corona-virus on top company’s growth. This research report categorizes as the key players in the Hot plasma viscosity and also gives a comprehensive study of Covid-19 impact analysis of the by regions like (Americas, Europe APAC, and EMEA).
The report also includes the profiles of key plasma viscosity companies along with their SWOT analysis and strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of the last three years, key developments in the past five years.
Anecdotal reports about the thick blood of Covid-19 patients have poured in from clinicians around the world, and a study recently published in The Lancet has now found that critically ill Covid-19 patients in Emory Healthcare’s intensive care unit (ICU) had plasma viscosity levels above the normal range. The sickest Emory patients had the highest plasma viscosity levels, more than double what is normal in some cases, and were more likely to have blood clots.
If plasma viscosity of Covid-19 patients is regularly tested, doctors will be able to see when levels are rising ahead of time and administer anti-clotting medication earlier in a patient’s treatment, potentially preventing further deterioration.
